The gut microbiome has been implicated in cancer in several ways, as specific microbial
signatures are known to promote cancer development and influence safety, tolerability and …

Gene therapy (GT) and photothermal therapy (PTT) have emerged as promising alternatives
to chemotherapy and radiotherapy for cancer treatment, offering noninvasiveness and …

Despite guidelines for detection and treatment of Helicobacter pylori infection,
recommendations to test patients before and after therapy are commonly not followed in the …

Background & Aims The long-term trend in gastric cancer rates has rarely been reported
from a global perspective. We aimed to explore the past temporal trends (1988–2012) in …

Background The initial step for noncardia gastric carcinogenesis is atrophic gastritis, driven
by either Helicobacter pylori infection or autoimmunity. In recent decades, the prevalence …

OBJECTIVES: Gastritis OLGA-staging ranks the risk for gastric cancer (GC) in progressive
stages (0-IV). This long-term follow-up study quantifies the GC risk associated with each …

Objective Helicobacter pylori infection is mostly a family-based infectious disease. To
facilitate its prevention and management, a national consensus meeting was held to review …

The inflammatory spectrum of gastric diseases includes different clinico-pathological
entities, the etiology of which was recently established in the international Kyoto …

Gastric cancer (GC) represents a leading cause of cancer related morbidity and mortality
worldwide accounting for more than 1 million of newly diagnosed cases and thousands of …

Background One‐week triple therapy with vonoprazan is endorsed by Japanese guidelines
as an alternative to proton pump inhibitor (PPI)‐based triple therapy for first‐line …